193 related articles for article (PubMed ID: 10696099)
1. Modulation of peristalsis by cannabinoid CB(1) ligands in the isolated guinea-pig ileum.
Izzo AA; Mascolo N; Tonini M; Capasso F
Br J Pharmacol; 2000 Mar; 129(5):984-90. PubMed ID: 10696099
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus.
Coutts AA; Pertwee RG
Br J Pharmacol; 1997 Aug; 121(8):1557-66. PubMed ID: 9283688
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.
Ross RA; Brockie HC; Fernando SR; Saha B; Razdan RK; Pertwee RG
Br J Pharmacol; 1998 Nov; 125(6):1345-51. PubMed ID: 9863666
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
Yousif MH; Oriowo MA
Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.
Duncan M; Kendall DA; Ralevic V
J Pharmacol Exp Ther; 2004 Oct; 311(1):411-9. PubMed ID: 15205450
[TBL] [Abstract][Full Text] [Related]
6. Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum.
López-Redondo F; Lees GM; Pertwee RG
Br J Pharmacol; 1997 Sep; 122(2):330-4. PubMed ID: 9313943
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
Ihenetu K; Molleman A; Parsons ME; Whelan CJ
Eur J Pharmacol; 2003 Jan; 458(1-2):207-15. PubMed ID: 12498928
[TBL] [Abstract][Full Text] [Related]
8. A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis.
Gross A; Terraza A; Marchant J; Bouaboula M; Ouahrani-Bettache S; Liautard JP; Casellas P; Dornand J
J Leukoc Biol; 2000 Mar; 67(3):335-44. PubMed ID: 10733093
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands.
Smith SR; Terminelli C; Denhardt G
Eur J Pharmacol; 2001 Aug; 425(1):73-83. PubMed ID: 11672577
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain.
Kathmann M; Bauer U; Schlicker E; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757
[TBL] [Abstract][Full Text] [Related]
11. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F
Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417
[TBL] [Abstract][Full Text] [Related]
12. Modulation of peristalsis in the guinea-pig isolated small intestine by exogenous and endogenous opioids.
Waterman SA; Costa M; Tonini M
Br J Pharmacol; 1992 Aug; 106(4):1004-10. PubMed ID: 1356564
[TBL] [Abstract][Full Text] [Related]
13. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice.
Smith SR; Terminelli C; Denhardt G
J Pharmacol Exp Ther; 2000 Apr; 293(1):136-50. PubMed ID: 10734163
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to cannabinoid response on the myenteric plexus of guinea-pig ileum and human small intestinal strips.
Guagnini F; Cogliati P; Mukenge S; Ferla G; Croci T
Br J Pharmacol; 2006 Aug; 148(8):1165-73. PubMed ID: 16783406
[TBL] [Abstract][Full Text] [Related]
15. Effect of CB1 Ligands on Neurogenic and Myogenic Contractile Responses in the Guinea-Pig Ileum.
Donnerer J; Liebmann I
Pharmacology; 2018; 101(5-6):330-336. PubMed ID: 29627825
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid inhibition of guinea-pig intestinal peristalsis via inhibition of excitatory and activation of inhibitory neural pathways.
Heinemann A; Shahbazian A; Holzer P
Neuropharmacology; 1999 Sep; 38(9):1289-97. PubMed ID: 10471082
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
Ihenetu K; Molleman A; Parsons M; Whelan C
Eur J Pharmacol; 2003 Mar; 464(2-3):207-15. PubMed ID: 12620515
[TBL] [Abstract][Full Text] [Related]
18. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human.
Martin RS; Luong LA; Welsh NJ; Eglen RM; Martin GR; MacLennan SJ
Br J Pharmacol; 2000 Apr; 129(8):1707-15. PubMed ID: 10780977
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat.
Coruzzi G; Adami M; Coppelli G; Frati P; Soldani G
Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):715-8. PubMed ID: 10619190
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine.
Pertwee RG; Fernando SR; Nash JE; Coutts AA
Br J Pharmacol; 1996 Aug; 118(8):2199-205. PubMed ID: 8864562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
